Other languages Cerevel Therapeutics Holdings, Inc.

Equities

CERE

US15678U1280

Market Closed - Nasdaq Other stock markets 01:30:00 27/04/2024 am IST			5-day change	1st Jan Change
42.47 ^USD	+0.95%		+0.62%	+0.17%

18/04	Sector Update: Health Care Stocks Mixed Pre-Bell Thursday	MT
18/04	Cerevel Therapeutics' Potential Parkinson's Treatment Meets Primary Endpoint in Phase 3 Study	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cerevel Therapeutics' Parkinson's disease drug meets main goal in late-stage study	18/04
Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson?s Disease	18/04
Actinogen Medical Notifies of Errors on M&A Slide in Recent Presentation	26/03
Cerevel Therapeutics Holdings Insider Sold Shares Worth $2,057,890, According to a Recent SEC Filing	05/03
Cerevel Therapeutics Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
Sector Update: Health Care Stocks Gain Late Afternoon	23/02
AbbVie Plans $13 Billion Bond Sale to Fund Acquisitions	23/02
AbbVie eyes selling at least $13 bln of bonds to fund M&A, Bloomberg reports	22/02
AbbVie CEO to Retire; COO Robert Michael Named Successor	21/02
BioPharma Credit gets USD50.6 million from Abbvie's ImmunoGen purchase	13/02
AbbVie Completes $10.1 Billion Acquisition of ImmunoGen, Lowers Q1 Adjusted EPS Guidance	12/02
Omzetdaling Abbvie valt mee	02/02
AbbVie profit beats estimates as Humira, Botox sales weather hit from rivals	02/02
Neumora Therapeutics Names Kaya Pai Panandiker as Chief Commercial Officer	22/01
Cerevel Therapeutics Holdings Insider Sold Shares Worth $424,700, According to a Recent SEC Filing	29/12
Cerevel Therapeutics Holdings Insider Sold Shares Worth $331,608, According to a Recent SEC Filing	28/12
Cerevel Therapeutics Holdings Insider Sold Shares Worth $571,972, According to a Recent SEC Filing	22/12
Cerevel Therapeutics Holdings Insider Sold Shares Worth $259,144, According to a Recent SEC Filing	22/12
Cerevel Therapeutics Holdings Insider Sold Shares Worth $292,945, According to a Recent SEC Filing	22/12
Cerevel Therapeutics Holdings Insider Sold Shares Worth $326,788, According to a Recent SEC Filing	22/12

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Cerevel Therapeutics Holdings, Inc.

Equities

CERE

US15678U1280

Other languages

Filters